Role Summary

The Sr. Manager, Retail Pharmacy Drug Margin Analytics plays a critical role within US Oncology Network (USON) Finance, serving as the subject matter expert for the financial performance of practice-based Medically Integrated Dispensing (MID) oral oncolytic programs across the network. This position is accountable for analyzing Retail Pharmacy/MID activity at the product (NDC/drug) level, translating dispensing economics into clear, actionable financial insights, and supporting forecasting, budgeting, and planning for the various USON practices.

This role partners closely with practice leadership, FP&A, GPO, Managed Care, Pharmacy Operations, and Revenue Cycle teams to develop a consistent framework for measuring retail pharmacy drug margin performance—including definitions, methodology, and executive-ready reporting. It leads modeling and scenario analysis across key margin drivers (script volume, drug mix, acquisition cost, payer reimbursement, reba...